Terminology Distinction
The terms "refractory chronic cough" and "intractable chronic cough" are essentially synonymous in clinical practice, both describing chronic cough that persists despite appropriate treatment of identifiable underlying conditions. However, the medical literature and guidelines predominantly use "refractory chronic cough" (RCC) as the standard terminology, while "intractable" is less commonly used and lacks formal definition in contemporary guidelines 1, 2.
Key Definitions
Refractory Chronic Cough (RCC):
- Cough lasting >8 weeks that persists despite guideline-based treatment of identified treatable traits (asthma, rhinosinusitis, GERD, medication-induced causes) 2
- Prevalence: approximately 4.0-4.2% of adults with chronic cough 3
- Represents a distinct clinical entity with neuronal hypersensitivity as the underlying mechanism 4, 5
Intractable Chronic Cough:
- This term lacks formal definition in current CHEST guidelines 6 and recent consensus statements 2
- When used colloquially, it implies the same clinical scenario as RCC—a cough that cannot be controlled or "tamed"
- Not a standardized term in contemporary cough literature
Clinical Framework
The modern approach recognizes RCC alongside "unexplained chronic cough" (UCC) as manifestations of cough hypersensitivity syndrome 1, 7. These conditions share:
- Dry, persistent cough with urge-to-cough sensation
- Laryngeal paresthesia (throat tickle, irritation)
- Hypersensitivity to chemical, thermal, and mechanical triggers
- Central and peripheral neuronal hypersensitivity 5
Practical Implications
Use "refractory chronic cough" in clinical documentation and communication because:
- It has a formal ICD-10 code (U69.6 in German version) 4
- It's the term used in FDA-approved drug trials (e.g., Gefapixant) 4
- It's standardized across international guidelines and consensus statements 2
- It clearly distinguishes between cough as a symptom versus cough as a disease entity 4
Common pitfall: Avoid using "intractable" as it may cause confusion in literature searches, insurance coding, and clinical trial enrollment, where "refractory" is the established terminology.